You are here

  • Home
  • Archive
  • Volume 94, Issue 4
  • Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

Citation Tools

Article menu
Multiple sclerosis
Original research
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Aiello A, Coppola A, Ruggieri S, et al
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Journal of Neurology, Neurosurgery & Psychiatry 2023;94:290-299.